| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/28/2007 | EP1767652A1 Gene marker and utilization of the same |
| 03/28/2007 | EP1767650A1 Method of screening compound directly activating glycogen synthase |
| 03/28/2007 | EP1767649A1 Assay of ubiquitinization of synoviolin and use thereof in screening |
| 03/28/2007 | EP1767648A1 Method for measuring enzyme activity and column for use in measuring enzyme activity |
| 03/28/2007 | EP1767647A1 Method of judging properties of mammalian cell and method of diagnosing cancer |
| 03/28/2007 | EP1767646A1 Probe for detection/determination of inositol-1,4,5-triphosphoric acid and method of detecting/determining inositol-1,4,5-triphosphoric acid with the same |
| 03/28/2007 | EP1767641A1 Antigenic neisserial peptides |
| 03/28/2007 | EP1767638A2 Mutation associated with epilepsy |
| 03/28/2007 | EP1767637A1 Mutation associated with epilepsy |
| 03/28/2007 | EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 03/28/2007 | EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/28/2007 | EP1767629A2 Methods for the detection, analysis and isolation of nascent proteins |
| 03/28/2007 | EP1767627A1 Anti-perp antibody |
| 03/28/2007 | EP1767621A1 Method of purifying environmental dna and method of efficiently screening protein-encoding gene from environmental dna |
| 03/28/2007 | EP1767619A1 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor |
| 03/28/2007 | EP1767551A1 Molecule recognition polymer enabling reconstruction of recognition field for target molecule and method of producing the same |
| 03/28/2007 | EP1767511A1 Macromolecular compound bond evaluating method |
| 03/28/2007 | EP1767263A2 Microchip and liquid mixing method and blood testing method using this microchip |
| 03/28/2007 | EP1767192A2 Cationic lipid compositions targeting angiogenic endothelial cells |
| 03/28/2007 | EP1766659A2 Mass spectrometry with selective ion filtration by digital thresholding |
| 03/28/2007 | EP1766420A1 Device and method for automatically analysing blood samples |
| 03/28/2007 | EP1766416A1 Use of standards for monitoring alterations of peptide and protein samples |
| 03/28/2007 | EP1766415A1 Methods for measuring chloride channel conductivity |
| 03/28/2007 | EP1766414A2 Methods and compositions to promote bone homeostasis |
| 03/28/2007 | EP1766413A2 Expression quantification using mass spectrometry |
| 03/28/2007 | EP1766412A2 Compositions and methods for quantification of serum glycoproteins |
| 03/28/2007 | EP1766411A2 Method for determining a tissue degradation process by detection of comp neoepitopes |
| 03/28/2007 | EP1766410A1 Methods for determining conformational changes and self-assembly of proteins |
| 03/28/2007 | EP1766409A2 Fluorescent isotope tags and their method of use |
| 03/28/2007 | EP1766408A2 Methods and compositions for the detection of ovarian cancer |
| 03/28/2007 | EP1766407A2 Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells |
| 03/28/2007 | EP1766406A2 Anti-cancer activity of an anti-thymidine kinase monoclonal antibody |
| 03/28/2007 | EP1766405A1 Method of quantifying the cell-binding properties of a medical device |
| 03/28/2007 | EP1766404A1 Novel microfluidic system and method for capturing cells |
| 03/28/2007 | EP1766403A2 Homo and heterodimer proteins of the abcg family, methods for detection and screening modulators thereof |
| 03/28/2007 | EP1766402A2 Device and method for analysis of interactions between biomolecules |
| 03/28/2007 | EP1766401A1 Method for the simple and rapid detection of cells and biomolecules by means of paramagnetic particles |
| 03/28/2007 | EP1766400A1 Methods and apparatuses for conducting assays |
| 03/28/2007 | EP1766399A2 Method of determining the presence and/or concentration of substances of interest in fluids |
| 03/28/2007 | EP1766398A1 Method for detecting molecular surface interactions |
| 03/28/2007 | EP1766397A2 Analysis of intracellular modifications |
| 03/28/2007 | EP1766396A2 Method of passive immunization against disease or disorder characterized by amyloid aggregation with diminished risk of neuroinflammation |
| 03/28/2007 | EP1766395A2 Method for the early detection of renal disease and injury |
| 03/28/2007 | EP1766394A2 System and method for grouping precursor and fragment ions using selected ion chromatograms |
| 03/28/2007 | EP1766393A2 Mhc bridging system for detecting ctl-mediated lysis of antigen presenting cells |
| 03/28/2007 | EP1766392A1 Diagnostic testing process and apparatus incorporating controlled sample flow |
| 03/28/2007 | EP1766391A1 Novel methods of diagnosis of treatment of p. aeruginosa infection and reagents therefor |
| 03/28/2007 | EP1766390A2 Novel means and methods for the treatment of hearing loss and phantom hearing |
| 03/28/2007 | EP1766389A1 A method of cell isolation |
| 03/28/2007 | EP1766388A2 Stable isotope labeled polypeptide standards for protein quantitation |
| 03/28/2007 | EP1766387A2 An innovative screening method for coronary heart disease and stroke |
| 03/28/2007 | EP1766386A1 Product shelf life monitoring systems |
| 03/28/2007 | EP1766385A1 Measuring device and method for measuring at least one environmental parameter |
| 03/28/2007 | EP1766384A1 Gas-monitoring assembly comprising one or more gas sensors and one or more getters, and method of using same |
| 03/28/2007 | EP1766378A1 Method and apparatus for meat scanning |
| 03/28/2007 | EP1766376A1 Light guide test sensor for use in determining an analyte in a fluid sample and methods for manufacturing the same |
| 03/28/2007 | EP1766372A1 Devices and methods for product authentication and/or monitoring |
| 03/28/2007 | EP1766371A2 Integrated glucose monitors and measurement of analytes via molecular oxygen modulation of dye fluorescence lifetime |
| 03/28/2007 | EP1766366A2 Processing of particles |
| 03/28/2007 | EP1766361A1 Spot test kit for explosives detection |
| 03/28/2007 | EP1766098A2 Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same |
| 03/28/2007 | EP1766095A2 Detection of protein translocation by beta-galactosidase reporter fragment complementation |
| 03/28/2007 | EP1766093A2 Antibodies against clostridium difficile toxins and uses thereof |
| 03/28/2007 | EP1766092A2 Target-specific compomers and methods of use |
| 03/28/2007 | EP1766091A2 Biomarkers for monitoring inhibition of impdh pathway |
| 03/28/2007 | EP1766087A2 Jm-27 asa a marker of benign prostatic hyperplasia |
| 03/28/2007 | EP1766085A2 Aptamer-nanoparticle conjugates and method of use for target analyte detection |
| 03/28/2007 | EP1766082A2 Cog47 protein and s100beta gene polymorphism |
| 03/28/2007 | EP1766079A2 Diagnosing or predicting the course of breast cancer |
| 03/28/2007 | EP1766077A2 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder |
| 03/28/2007 | EP1766076A2 Methods for target molecule detection using siderophores and related compositions |
| 03/28/2007 | EP1766069A2 Devices and methods for removing target agents from a sample |
| 03/28/2007 | EP1766068A2 Egfr mutations |
| 03/28/2007 | EP1766067A1 Methods for predicting therapeutic response to agents acting on the growth hormone receptor |
| 03/28/2007 | EP1766063A2 Methods and kits to detect hereditary angioedema type iii |
| 03/28/2007 | EP1766060A1 Methods of diagnosing and prognosticating solid tumors and melanoma |
| 03/28/2007 | EP1766054A1 Compositions and methods |
| 03/28/2007 | EP1766048A2 Method and device for monitoring aspirin response |
| 03/28/2007 | EP1766045A2 Hematology reference control containing an immature granulocyte component |
| 03/28/2007 | EP1766043A2 Computer systems and methods for constructing biological classifiers and uses thereof |
| 03/28/2007 | EP1766042A2 Diagnostics and therapeutics for diseases associated with chymase (cma1) |
| 03/28/2007 | EP1766041A2 Methods for identifying risk of breast cancer and treatment thereof |
| 03/28/2007 | EP1766027A1 Fluorescent protein |
| 03/28/2007 | EP1766017A1 Tumor specific antibody |
| 03/28/2007 | EP1766016A1 Functional screening assay |
| 03/28/2007 | EP1766015A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
| 03/28/2007 | EP1766011A1 Polypeptide ligands containing linkers |
| 03/28/2007 | EP1765991A1 Acetyl coa carboxylase splice variant and uses thereof |
| 03/28/2007 | EP1765987A1 Enzymatic modification of cell-surface h antigen by glycosyltransferases |
| 03/28/2007 | EP1765868A2 Transferrin receptor antibodies |
| 03/28/2007 | EP1765867A1 Monoclonal antibodies to hiv-1 vpr and methods of using same |
| 03/28/2007 | EP1765863A1 Peptide-based compounds |
| 03/28/2007 | EP1765851A2 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification |
| 03/28/2007 | EP1765845A1 Stable cyanine dye phosphoramidites |
| 03/28/2007 | EP1765502A2 Dissolvable films and methods including the same |
| 03/28/2007 | EP1765500A2 Device with removal member for detecting an analyte in a liquid sample |
| 03/28/2007 | EP1765487A1 Reactor mixing |
| 03/28/2007 | EP1765390A2 Method for preventing and treating alzheimer´s disease |
| 03/28/2007 | EP1765381A1 Treatment of neurological disorders with haematopoietic growth factors |
| 03/28/2007 | EP1765357A2 Use of atp analogues for treatment of cardiovascular diseases |